Clinical Trial Update: Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the use of IFX-1 as an alternative to steroids in Granulomatosis with Polyangiitis and Microscopic Polyangiitis; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• IFX-1 (vilobelimab)

Snippet

Sponsor: InflaRx GmbH | Conditions: Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) | Phase 2 | Status: COMPLETED | Results posted: 2022-08-25